Status:
RECRUITING
Comparing Super High-flux and High-flux Dialyzer Performance Among Hemodialysis Patient With Sepsis : a Randomized Control Trial
Lead Sponsor:
Navamindradhiraj University
Conditions:
The Efficacy and Safety for Super High-flux Dialyzer in Case of Sepsis in ESKD
End Stage Kidney Disease (ESRD)
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Comparing the efficacy of superhigh-flux dialyzer with high-flux dialyzer in ESKD patient who have sepsis to improve mortality and sepsis outcome, an open label randomized control trial.
Detailed Description
Sepsis in people who have ESKD is the risk of developing poor outcome. Cytokines play a role in the process of sepsis and cause the worsening clinical outcome despite definitive antibiotic treatment. ...
Eligibility Criteria
Inclusion
- ESKD patients who have sepsis condition with high interleukin-6 (IL-6 \> 50 pg/ml)
Exclusion
- Patients who needed dialysis with continuous kidney replacement therapy, vulnerable patient, include pregnant woman, patient who expected to pass away within the 24 hours.
- Patients who have the history of allergic dialyzer reaction to dialyzer which used in this trial.
Key Trial Info
Start Date :
July 25 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2026
Estimated Enrollment :
202 Patients enrolled
Trial Details
Trial ID
NCT06989892
Start Date
July 25 2024
End Date
October 1 2026
Last Update
May 25 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Navamindhradhiraj university
Dusit, Bangkok, Thailand, 11130